Coordinated ubiquitination and phosphorylation of RIP1 regulates necroptotic cell death

Cell Death and Differentiation

Volumn 24, Issue 1, 2017, Pages 26-37

  De Almagro, M Cristina ^a   Goncharov, Tatiana ^a   Izrael Tomasevic, Anita ^a   Duttler, Stefanie ^a   Kist, Matthias ^a   Varfolomeev, Eugene ^a   Wu, Xiumin ^a   Lee, Wyne P ^a   Murray, Jeremy ^a   Webster, Joshua D ^a   Yu, Kebing ^a   Kirkpatrick, Donald S ^a   Newton, Kim ^a   Vucic, Domagoj ^a  

^a GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MIXED LINEAGE KINASE LIKE; PROTEIN KINASE; RECEPTOR INTERACTING PROTEIN KINASE 1; RECEPTOR INTERACTING PROTEIN KINASE 3; UNCLASSIFIED DRUG; AGFG1 PROTEIN, HUMAN; BENZYLOXYCARBONYL-VALYL-ALANYL-ASPARTIC ACID; BV6 PEPTIDE; CREATININE; MLKL PROTEIN, HUMAN; NUCLEOPORIN; OLIGOPEPTIDE; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE; RIPK3 PROTEIN, HUMAN; RNA BINDING PROTEIN; TUMOR NECROSIS FACTOR;

ANTIBODY AFFINITY; ARTICLE; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; MASS SPECTROMETRY; NECROPTOSIS; PRIORITY JOURNAL; PROTEIN ASSEMBLY; SIGNAL TRANSDUCTION; UBIQUITINATION; ANIMAL; APOPTOSIS; BLOOD; CELL LINE; COMPLICATION; CRISPR CAS SYSTEM; DEFICIENCY; DRUG EFFECTS; GENETICS; HEK293 CELL LINE; HT-29 CELL LINE; KIDNEY DISEASE; METABOLISM; MOUSE; PATHOLOGY; PHOSPHORYLATION; PROTEIN TERTIARY STRUCTURE; REPERFUSION INJURY;

ANIMALS; APOPTOSIS; CELL LINE; CREATININE; CRISPR-CAS SYSTEMS; HEK293 CELLS; HT29 CELLS; HUMANS; KIDNEY DISEASES; MICE; NUCLEAR PORE COMPLEX PROTEINS; OLIGOPEPTIDES; PHOSPHORYLATION; PROTEIN KINASES; PROTEIN STRUCTURE, TERTIARY; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES; REPERFUSION INJURY; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; UBIQUITINATION;

EID: 84982175027     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2016.78     Document Type: Article

References (46)

1. Steller H. Mechanisms, genes of cellular suicide. Science 1995; 267: 1445-1449.
2. Linkermann A, Stockwell BR, Krautwald S, Anders HJ. Regulated cell death, inflammation: an auto-amplification loop causes organ failure. Nat Rev Immunol 2014; 14: 759-767.
3. Salvesen GS, Abrams JM. Caspase activation-stepping on the gas or releasing the brakes Lessons from humans, flies. Oncogene 2004; 23: 2774-2784.
4. Linkermann A, Green DR. Necroptosis. N Engl J Med 2014; 370: 455-465.
5. Newton K. RIPK1, RIPK3: critical regulators of inflammation, cell death. Trends Cell Biol 2015; 25: 347-353.
6. Vanden Berghe T, Linkermann A, Jouan-Lanhouet S, Walczak H, Vandenabeele P. Regulated necrosis: the expanding network of non-apoptotic cell death pathways. Nat Rev Mol Cell Biol 2014; 15: 135-147.
7. Silke J, Brink R. Regulation of TNFRSF, innate immune signalling complexes by TRAFs, cIAPs. Cell Death Differ 2010; 17: 35-45.
8. Varfolomeev E, Goncharov T, Fedorova AV, Dynek JN, Zobel K, Deshayes K et al. c-IAP1, c-IAP2 are critical mediators of tumor necrosis factor alpha (TNF)-induced NF-B activation. J Biol Chem 2008; 283: 24295-24299.
9. Haas TL, Emmerich CH, Gerlach B, Schmukle AC, Cordier SM, Rieser E et al. Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex, is required for TNF-mediated gene induction. Mol Cell 2009; 36: 831-844.
10. Varfolomeev E, Goncharov T, Maecker H, Zobel K, Komuves LG, Deshayes K et al. Cellular inhibitors of apoptosis are global regulators of NF-kappaB, MAPK activation by members of the TNF family of receptors. Sci Signal 2012; 5: ra22.
11. Tokunaga F. Linear ubiquitination-mediated NF-kappaB regulation, its related disorders. J Biochem 2013; 154: 313-323.
12. Dynek JN, Goncharov T, Dueber EC, Fedorova AV, Izrael-Tomasevic A, Phu L et al. c-IAP1, UbcH5 promote K11-linked polyubiquitination of RIP1 in TNF signalling. EMBO J 2010; 29: 4198-4209.
13. Gerlach B, Cordier SM, Schmukle AC, Emmerich CH, Rieser E, Haas TL et al. Linear ubiquitination prevents inflammation, regulates immune signalling. Nature 2011; 471: 591-596.
14. Silke J, Vucic D. IAP family of cell death, signaling regulators. Methods Enzymol 2014; 545: 35-65.
15. Sun L, Wang H, Wang Z, He S, Chen S, Liao D et al. Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell 2012; 148: 213-227.
16. Zhao J, Jitkaew S, Cai Z, Choksi S, Li Q, Luo J et al. Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosis. Proc Natl Acad Sci USA 2012; 109: 5322-5327.
17. Dondelinger Y, Declercq W, Montessuit S, Roelandt R, Goncalves A, Bruggeman I et al. MLKL compromises plasma membrane integrity by binding to phosphatidylinositol phosphates. Cell Rep 2014; 7: 971-981.
18. Murphy JM, Czabotar PE, Hildebrand JM, Lucet IS, Zhang JG, Alvarez-Diaz S et al. The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism. Immunity 2013; 39: 443-453.
19. Oberst A. Death in the fast lane: what's next for necroptosis FEBS J 2015; 283: 2616-2625.
20. Kaiser WJ, Daley-Bauer LP, Thapa RJ, Mandal P, Berger SB, Huang C et al. RIP1 suppresses innate immune necrotic as well as apoptotic cell death during mammalian parturition. Proc Natl Acad Sci USA 2014; 111: 7753-7758.
21. Newton K, Dugger DL, Wickliffe KE, Kapoor N, de Almagro MC, Vucic D et al. Activity of protein kinase RIPK3 determines whether cells die by necroptosis or apoptosis. Science 2014; 343: 1357-1360.
22. Hershko A, Ciechanover A. The ubiquitin system. Annu Rev Biochem 1998; 67: 425-479.
23. Ikeda F, Dikic I. Atypical ubiquitin chains: new molecular signals. 'Protein Modifications: Beyond the Usual Suspects' review series. EMBO Rep 2008; 9: 536-542.
24. Peltzer N, Darding M, Walczak H. Holding RIPK1 on the ubiquitin leash in TNFR1 signaling. Trends Cell Biol 2016; 26: 445-461.
25. Vucic D, Dixit VM, Wertz IE. Ubiquitylation in apoptosis: a post-translational modification at the edge of life, death. Nat Rev Mol Cell Biol 2011; 12: 439-452.
26. de Almagro MC, Goncharov T, Newton K, Vucic D. Cellular IAP proteins, LUBAC differentially regulate necrosome-associated RIP1 ubiquitination. Cell Death Dis 2015; 6: e1800.
27. Lawlor KE, Khan N, Mildenhall A, Gerlic M, Croker BA, D'Cruz AA et al. RIPK3 promotes cell death, NLRP3 inflammasome activation in the absence of MLKL. Nat Commun 2015; 6: 6282.
28. Moriwaki K, Chan FK. Regulation of RIPK3, RHIM-dependent necroptosis by the proteasome. J Biol Chem 2016; 291: 5948-5959.
29. Dondelinger Y, Darding M, Bertrand MJ, Walczak H. Poly-ubiquitination in TNFR1-mediated necroptosis. Cell Mol Life Sci 2016; 73: 2165-2176.
30. Cho YS, Challa S, Moquin D, Genga R, Ray TD, Guildford M et al. Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis, virus-induced inflammation. Cell 2009; 137: 1112-1123.
31. He S, Wang L, Miao L, Wang T, Du F, Zhao L et al. Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. Cell 2009; 137: 1100-1111.
32. Linkermann A, Brasen JH, Himmerkus N, Liu S, Huber TB, Kunzendorf U et al. Rip1 (receptor-interacting protein kinase 1) mediates necroptosis, contributes to renal ischemia/reperfusion injury. Kidney Int 2012; 81: 751-761.
33. Newton K, Dugger DL, Maltzman A, Greve JM, Hedehus M, Martin-McNulty B et al. RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation, tissue injury. Cell Death Differ 2016 (e-pub ahead of print 13 May 2016; doi:10. 1038/cdd. 2016. 46).
34. Popovic D, Vucic D, Dikic I. Ubiquitination in disease pathogenesis, treatment. Nat Med 2014; 20: 1242-1253.
35. Mocarski ES, Upton JW, Kaiser WJ. Viral infection, the evolution of caspase 8-regulated apoptotic, necrotic death pathways. Nat Rev Immunol 2012; 12: 79-88.
36. Takahashi N, Duprez L, Grootjans S, Cauwels A, Nerinckx W, DuHadaway JB et al. Necrostatin-1 analogues: critical issues on the specificity, activity, in vivo use in experimental disease models. Cell Death Dis 2012; 3: e437.
37. Mandal P, Berger SB, Pillay S, Moriwaki K, Huang C, Guo H et al. RIP3 induces apoptosis independent of pronecrotic kinase activity. Mol Cell 2014; 56: 481-495.
38. Varfolomeev E, Blankenship JW, Wayson SM, Fedorova AV, Kayagaki N, Garg P et al. IAP antagonists induce autoubiquitination of c-IAPs, NF-B activation, TNF-dependent apoptosis. Cell 2007; 131: 669-681.
39. Goncharov T, Niessen K, de Almagro MC, Izrael-Tomasevic A, Fedorova AV, Varfolomeev E et al. OTUB1 modulates c-IAP1 stability to regulate signalling pathways. EMBO J 2013; 32: 1103-1114.
40. Varfolomeev E, Izrael-Tomasevic A, Yu K, Bustos D, Goncharov T, Belmont LD et al. Ubiquitination profiling identifies sensitivity factors for IAP antagonist treatment. Biochem J 2015; 466: 45-54.
41. Rappsilber J, Ishihama Y, Mann M. Stop, go extraction tips for matrix-assisted laser desorption/ionization, nanoelectrospray, LC/MS sample pretreatment in proteomics. Anal Chem 2003; 75: 663-670.
42. Yu K, Phu L, Varfolomeev E, Bustos D, Vucic D, Kirkpatrick DS. Immunoaffinity enrichment coupled to quantitative mass spectrometry reveals ubiquitin-mediated signaling events. J Mol Biol 2015; 427: 2121-2134.
43. Anania VG, Pham VC, Huang X, Masselot A, Lill JR, Kirkpatrick DS. Peptide level immunoaffinity enrichment enhances ubiquitination site identification on individual proteins. Mol Cell Proteomics 2014; 13: 145-156.
44. Beausoleil SA, Villen J, Gerber SA, Rush J, Gygi SP. A probability-based approach for high-throughput protein phosphorylation analysis, site localization. Nat Biotechnol 2006; 24: 1285-1292.
45. Bakalarski CE, Elias JE, Villen J, Haas W, Gerber SA, Everley PA et al. The impact of peptide abundance, dynamic range on stable-isotope-based quantitative proteomic analyses. J Proteome Res 2008; 7: 4756-4765.
46. Kirkpatrick DS, Bustos DJ, Dogan T, Chan J, Phu L, Young A et al. Phosphoproteomic characterization of DNA damage response in melanoma cells following MEK/PI3K dual inhibition. Proc Natl Acad Sci USA 2013; 110: 19426-19431.